Drugs / NVP-2203-R
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT05725252 Comparator | May → Jun 2023 | — | NVP Healthcare | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NVP-2203-R | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05725252 ↗ |
| Route | Oral | “oral administration of investigational product once daily” NCT05725252 ↗ |